Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buserelin and Low Dose hCG for Ovulation Triggering in IVF
NCT00627406Phase 4Completed
- Sponsor
- Regionshospitalet
- Start
- Jan 2009
- Primary completion
- Dec 2011
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of buserelin in ovarian hyperstimulation syndrome (OHSS), sponsored by Regionshospitalet. Started Jan 2009; status: completed.
02
Drugs
buserelin
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on NCT00627406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00627406.